Background: Olfactory neuroblastoma (ONB) is a rare malignancy that develops in the nasal cavity, with appendicular skeletal metastases being exceptionally uncommon. We report the case of a middle-aged male with ONB, presenting with an unusual biopsy-confirmed solitary metastasis to the left proximal femur.
Case Presentation: A 33-year-old male was previously diagnosed with olfactory neuroblastoma in the skull base after initial clinical presentation with progressive left-sided nasal obstruction for six months. He was treated with neoadjuvant chemotherapy, followed by local control via trans-sphenoidal resection in addition to postoperative radiotherapy and adjuvant chemotherapy. Two years later, the patient began experiencing left thigh pain. Radiographic imaging of the left femur revealed an ill-defined lesion in the midshaft with periosteal thickening, suggesting metastatic disease. The lesion caused significant bone destruction, ending up with a non-traumatic pathological fracture. A wide surgical resection of the proximal two-thirds of the femur was performed, followed by endoprosthetic reconstruction to restore structural integrity, joint function, and limb biomechanics. Postoperative management included physical rehabilitation to optimize functional recovery and maintain weight-bearing capacity.
Conclusion: This case underscores the importance of early identification of skeletal involvement in ONB, as prompt orthopedic intervention can prevent complications, improve mobility, and contribute to better oncological and functional outcomes. Advanced reconstructive techniques play a pivotal role in achieving durable results in cases involving skeletal metastasis of rare tumors like ONB.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1186/s12957-025-03727-z | DOI Listing |
World J Surg Oncol
March 2025
Department of Orthopedic Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Background: Olfactory neuroblastoma (ONB) is a rare malignancy that develops in the nasal cavity, with appendicular skeletal metastases being exceptionally uncommon. We report the case of a middle-aged male with ONB, presenting with an unusual biopsy-confirmed solitary metastasis to the left proximal femur.
Case Presentation: A 33-year-old male was previously diagnosed with olfactory neuroblastoma in the skull base after initial clinical presentation with progressive left-sided nasal obstruction for six months.
Cureus
February 2025
Medical Oncology, Instituto Português De Oncologia, Porto, PRT.
Esthesioneuroblastoma (ENB) is a rare malignant neoplasm of the nasal cavity. The clinical course is heterogeneous and, currently, there is no consensus regarding the correct management of this disease. We present the case of a 37-year-old man with a diagnosis of an ENB, progressing, two years after radical treatment with surgery and chemoradiotherapy, with spinal and leptomeningeal metastasis.
View Article and Find Full Text PDFJ Pers Med
January 2025
Unit of Otorhinolaryngology-Head and Neck Surgery, ASST Spedali Civili of Brescia, 25123 Brescia, Italy.
Meningeal metastasis (MM) from naso-ethmoidal malignancies (NEMs) is rare, its metastatic route is still debated, and its prognostic impact remains unclear. Our aim is to analyze a retrospective series of NEMs with non-contiguous MM to study the possible route of spread and the prognostic value of MM. The institutional database of SNC treated at the University of Brescia between 1995 and 2021 was reviewed.
View Article and Find Full Text PDFBMC Med Imaging
February 2025
Shanghai Institute of Medical Imaging, Fudan University, Shanghai, China.
Purpose: To develop MRI-based deep learning (DL) models for distinguishing sinonasal squamous cell carcinoma (SCC), adenoid cystic carcinoma (ACC) and olfactory neuroblastoma (ONB) and to evaluate whether the DL models could improve the diagnostic performance of Senior radiologist (SR) and Junior radiologist (JR).
Methods: This retrospective analysis consisted of 465 patients (229 sinonasal SCCs, 128 ACCs and 108 ONBs). The training and validation cohorts included 325 and 47 patients and the independent external testing cohort consisted of 93 patients.
Int Forum Allergy Rhinol
January 2025
Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine, Orange, California, USA.
Background: Olfactory neuroblastoma (ONB) is a rare sinonasal malignancy primarily treated with surgery. For tumors arising from the olfactory area, traditional treatment involves transcribriform resection of the anterior cranial fossa. Surgery can be performed with unilateral or bilateral resection depending on extent of involvement; however, there are currently no studies comparing outcomes between the two.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!